INNV
Get informed when a big investor buys or sells
+ FollowOvervalued by 165.5% based on the discounted cash flow analysis.
| Market cap | $1.22 Billion |
|---|---|
| Enterprise Value | $1.22 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.22 |
| Beta | 0.45 |
| Outstanding Shares | 135,704,645 |
| P/E Ratio | -54.83 |
|---|---|
| PEG | -34.5 |
| Price to Sales | 1.55 |
| Price to Book Ratio | 9.32 |
| Enterprise Value to Revenue | 1.31 |
| Enterprise Value to EBIT | 30.79 |
| Enterprise Value to Net Income | -40 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.41 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 12,400▼ 16.22% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 11.80%▲ 0.45% |
|---|---|
| Total Invested | $127.98M▲ 60.14% |
| Investors Holding | 102▲ 23.00% |
No data
InnovAge is a market leader in managing the care of high-cost, dual-eligible seniors. Its mission is to enable seniors to age independently in their own homes for as long as possible. Its patient-centered care model meaningfully improves...